Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c </= 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials.

Qian Lv,Jie Shen,Lin Miao,Binqi Ye,Cornelia Schepers,Arian Plat,Yongquan Shi

Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c </= 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials.

2020

Qian Lv
Jie Shen
Lin Miao
Binqi Ye
Cornelia Schepers
Arian Plat
Yongquan Shi

INTRODUCTION: Clinical guidelines suggest a glycated hemoglobin A1c (HbA1c) target of 70%) of the 1160 patients analyzed were treatment naive, and more than half had had diabetes for

Keywords:

Type 2 diabetes
Medicine
Linagliptin
Combination therapy
Endocrinology
Randomized controlled trial
Metformin
Glycemic
Diabetes mellitus
Hypoglycemia
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations